ADNeT, Monash University & Lilly sign innovative research collaboration
The Australian Dementia Network (ADNeT), Monash University, and Lilly Australia are proud to announce a new research collaboration aimed at deepening our understanding of the patient experience and societal impact of mild cognitive impairment and early Alzheimer’s disease. This landmark initiative represents the first collaboration of its kind in Australia between researchers, academia, and industry...
Read more
Breakthrough dementia treatment finally approved, but is our health system ready?
The Australian Dementia Network (ADNeT) welcomes the decision by the Therapeutic Goods Administration (TGA) to approve the use of donanemab in Australia. It is the first drug registered in Australia that has been proven to significantly slow the progression of Alzheimer’s disease. But it needs to be given at the first signs of the disease...
Read more
ADNeT NEWS – May 2025
Welcome to the latest edition of the ADNeT newsletter. We are on the cusp of significant progress in new drugs and blood tests for preventing, diagnosing and treating dementia. It is a critical time to support the research driving these innovations. At this end of the financial year, your tax deductible donation will advance dementia...
Read more